Name: The New Administration's First 90 Days – Impacts on Fundraising in the Life Sciences Industry
Start: 2025-04-24T20:00:00Z
End: 2025-04-24T21:00:00Z

The New Administration's First 90 Days – Impacts on Fundraising in the Life Sciences Industry

WSGR Events

Thursday, April 24, 2025

4:00 - 5:00 PM ET

Webinar

Add to calendar

Our experienced panel will discuss the first 90 days of the new administration and its impact on fundraising and investment in the life sciences sector.

The panel will explore:

The impact of FDA leadership changes, regulatory shifts, NIH grant freezes, and federal funding cuts on life sciences investment.
How investor sentiment, across VCs and LPs, is evolving in response to these changes, broader venture capital trends, and shifts in the IPO market.

Moderators: Squire Servance and Matthew Meyer
Panelists: Andrew Weisenfeld, Alex Chaloff, Patroski Lawson, and Tom White

Contacts

Sheridan Liaw

sliaw@wsgr.com

Presenters

Squire Servance

Senior Of Counsel

Squire Servance is Senior Of Counsel in the New York office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovation practice. Squire is an attorney and senior executive with extensive experience advising and leading life sciences organizations, including as managing partner of a biotech venture studio and fund and general counsel and corporate secretary for a Nasdaq listed life sciences company.

View Profile

Matthew J. Meyer

Chief Business Advisor, Life Sciences Business Advisory

San Francisco

Matthew J. Meyer is chief business advisor for life sciences at Wilson Sonsini Goodrich & Rosati. Based in San Francisco, Matthew leads the firm's life science business advisory practice—a newly formed, innovative resource aimed at providing start-up and emerging life sciences companies with business insights, capabilities, and strategies to help them thrive and address some of their most challenging issues.